Blog

01Aug

Substance Vol 8 Iss 1

posted by

31Jul

11Nov

Substance Vol 7 Iss 3

posted by

06Apr

When a child is exposed to illegal substance abuse they often also face other coexisting obstacles to a normal life - neglect, abuse, violence, and other vulnerabilities. Substance abuse is a disease, one that often prevents adults from doing what is in a child's best interests. Our environmental exposure test for children can help.

Our hair environmental exposure test is the only drug test designed to detect passive exposure to drugs and detect both native drugs and drug metabolites in the hair specimen. Drug metabolites are produced in the body only if drugs have been ingested. Children in drug exposed environments are most often not drug users themselves, so drug metabolites are typically absent in child specimens. However, the hair, like a sponge, can absorb non-metabolized drug (native drug) if it is exposed through things such as touching or being in contact with drugs or drug users.

Standard hair tests with other labs will only report a positive exposure result if drug metabolites are detected, even when the native drug is in the child's hair specimen. Our hair environmental exposure test reports a positive result if either native drugs or drug metabolites are detected.

A hair exposure test can provide evidence of drugs in a child's environment for the past 3 months. A positive test result suggests that the child has experienced one or more of the following: passive inhalation of drug smoke, contact with drug smoke, contact with sweat or sebum (skin oil) of a drug user, contact with the actual drug, or accidental or intentional ingestion of illegal drugs.

ChildGuard®  is the only child hair test designed to detect exposure to native drugs and drug metabolites.


17Mar

Substance Vol 7 Iss 1

posted by

09Sep

Alcohol Testing: Think 3-3-3

posted by

 

05May

Substance Vol 6 Iss 1

posted by

Des Plaines, IL - United States Drug Testing Laboratory, Inc. (USDTL), a forensic laboratory specializing in drug and alcohol testing using advanced specimens, has released a new assay to detect zolpidem (Ambien®) use in fingernail and hair specimens. Previously available only in urine and oral-fluid specimens, zolpidem testing in fingernails and hair offers forensic drug testing professionals new, powerful tools to meet their drug testing needs.

Since its approval in 1993 for the treatment of insomnia, zolpidem has become one of the most popular and most prescribed sleep aids. Zolpidem is a sedative-hypnotic medication that affects the same areas of the brain as benzodiazepines. In 2011, 39 million prescriptions for zolpidem products were written in the United States. [1]

Zolpidem use carries some risks of harm, especially when taken in combination with other substances. The number of emergency department visits related to zolpidem grew by 136% from 2004 (12,792) to 2011 (30,149). [2] Other substances were involved in 57% of those ED visits, including benzodiazepines (26%), narcotic pain relievers (25%), and alcohol (14%). [3]

The development of zolpidem testing is driven by USDTL’s ongoing commitment to be a leader in substance abuse and alcohol detection.  Zolpidem testing in fingernails and hair will be available on October 1st, 2014.

USDTL has made significant breakthroughs in detecting alcohol and other substances of abuse. They offer a wide range of testing services and specialize in hard to detect substances of abuse, customized assays, and advanced drug testing specimens.

References

1. IMS, Vector One: National (VONA) and Total Patient Tracker (TOT). Year 2011. Extracted June 2011.

2. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (May 1, 2013).  Emergency Department Visits for Adverse Reactions Involving the Insomnia Medication Zolpidem. Rockville, MD.

3. Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Visits. HHS Publication No. (SMA) 13-4760, DAWN Series D-39. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013.

0